Clinical Trials in Atlanta

Showing 961-980 of 9,468 trials

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

NCT07377747

The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation cohort of the TARPSWG recurrent RPS nomogram. The treatment decision (surgery alone, or preoperative RT +/- chemotherapy followed by surgery) is per the institutional multidisciplinary team recommendation.

Retroperitoneal Liposarcoma

Australia and New Zealand Sarcoma Association100 participantsStarted Sep 2024

Atlanta, Georgia, United States • Columbus, Ohio, United States • Houston, Texas, United States +6 more locations

Active Not RecruitingPhase 2/3< 1 mile

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

NCT05818553

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

SCN2A EncephalopathySCN8A Encephalopathy

Praxis Precision Medicines77 participantsStarted Aug 2023

Atlanta, Georgia, United States • Chicago, Illinois, United States • Minneapolis, Minnesota, United States +5 more locations

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Find Trials by Condition in Atlanta

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.